HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 2 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,708,547 | -0.3% | 784,444 | +7.1% | 0.01% | 0.0% |
| Q2 2023 | $25,778,673 | -5.1% | 732,551 | -12.0% | 0.01% | -11.1% |
| Q1 2023 | $27,165,726 | +84846.0% | 832,027 | +43.4% | 0.01% | 0.0% |
| Q4 2022 | $31,980 | -99.9% | 580,404 | +3.1% | 0.01% | -10.0% |
| Q3 2022 | $24,924,000 | +11.7% | 562,770 | +23.0% | 0.01% | +25.0% |
| Q2 2022 | $22,323,000 | +32.6% | 457,688 | +32.3% | 0.01% | +60.0% |
| Q1 2022 | $16,837,000 | +102.4% | 346,052 | +77.4% | 0.01% | +66.7% |
| Q4 2021 | $8,320,000 | +496.4% | 195,121 | +436.1% | 0.00% | – |
| Q3 2021 | $1,395,000 | – | 36,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |